Cargando…
NadA, a Novel Vaccine Candidate of Neisseria meningitidis
Neisseria meningitidis is a human pathogen, which, in spite of antibiotic therapy, is still a major cause of mortality due to sepsis and meningitis. Here we describe NadA, a novel surface antigen of N. meningitidis that is present in 52 out of 53 strains of hypervirulent lineages electrophoretic typ...
Autores principales: | Comanducci, Maurizio, Bambini, Stefania, Brunelli, Brunella, Adu-Bobie, Jeannette, Aricò, Beatrice, Capecchi, Barbara, Giuliani, Marzia Monica, Masignani, Vega, Santini, Laura, Savino, Silvana, Granoff, Dan M., Caugant, Dominique A., Pizza, Mariagrazia, Rappuoli, Rino, Mora, Marirosa |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193550/ https://www.ncbi.nlm.nih.gov/pubmed/12045242 http://dx.doi.org/10.1084/jem.20020407 |
Ejemplares similares
-
Vaccination against Neisseria meningitidis Using Three Variants of the Lipoprotein GNA1870
por: Masignani, Vega, et al.
Publicado: (2003) -
An Analysis of the Sequence Variability of Meningococcal fHbp, NadA and NHBA over a 50-Year Period in the Netherlands
por: Bambini, Stefania, et al.
Publicado: (2013) -
In silico Homology Modeling and Epitope Prediction of NadA as a Potential Vaccine Candidate in Neisseria meningitidis
por: Shahsavani, Narjes, et al.
Publicado: (2018) -
Role of ARF6, Rab11 and External Hsp90 in the Trafficking and Recycling of Recombinant-Soluble Neisseria meningitidis
Adhesin A (rNadA) in Human Epithelial Cells
por: Bozza, Giuseppe, et al.
Publicado: (2014) -
The Soluble Recombinant Neisseria meningitidis Adhesin NadA(Δ351–405) Stimulates Human Monocytes by Binding to Extracellular Hsp90
por: Cecchini, Paola, et al.
Publicado: (2011)